BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

117 related articles for article (PubMed ID: 3150588)

  • 1. [Behavior of Schistosoma mansoni strain LE, after passage through an accidentally infected human host].
    Araújo N; de Souza CP; Dias EP; Katz N
    Rev Soc Bras Med Trop; 1986; 19(4):213-8. PubMed ID: 3150588
    [No Abstract]   [Full Text] [Related]  

  • 2. Activity of oxamniquine at skin, pulmonary and sexual maturation phases, on a Schistosoma mansoni strain (R1) previously reported as resistant at the adult phase.
    Coelho PM; Ribeiro F; Mello RT; Lima e Silva FC; Nogueira-Machado JA
    Mem Inst Oswaldo Cruz; 1998; 93 Suppl 1():267-8. PubMed ID: 9921366
    [No Abstract]   [Full Text] [Related]  

  • 3. Resistance to oxamniquine of a Schistosoma mansoni strain isolated from patient submitted to repeated treatments.
    Coelho PM; Lima e Silva FC; Nogueira-Machado JA
    Rev Inst Med Trop Sao Paulo; 1997; 39(2):101-6. PubMed ID: 9394523
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Variation in response of Schistosoma mansoni strains to schistosomicides.
    Dias LC; Bruce JI; Coles GC
    Rev Inst Med Trop Sao Paulo; 1988; 30(2):81-5. PubMed ID: 3144034
    [No Abstract]   [Full Text] [Related]  

  • 5. Resistance to praziquantel: direct evidence from Schistosoma mansoni isolated from Egyptian villagers.
    Ismail M; Botros S; Metwally A; William S; Farghally A; Tao LF; Day TA; Bennett JL
    Am J Trop Med Hyg; 1999 Jun; 60(6):932-5. PubMed ID: 10403323
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Susceptibility to chemotherapeutic agents of Schistosoma mansoni isolates from patients treated with oxamniquine and praziquantel and not cured].
    Araújo N; de Souza CP; Passos LK; Simpson AJ; Dias Neto E; Pereira TR; Cerutti Júnior C; de Alencar FE; Dietze R; Katz N
    Rev Soc Bras Med Trop; 1996; 29(5):467-76. PubMed ID: 8966311
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Detection of praziquantel resistance in schistosomes.
    Liang YS; Coles GC; Doenhoff MJ
    Trop Med Int Health; 2000 Jan; 5(1):72. PubMed ID: 10672208
    [No Abstract]   [Full Text] [Related]  

  • 8. Effects of garlic on Schistosoma mansoni harbored in albino mice: molecular characterization of the host and parasite.
    Riad NH; Taha HA; Mahmoud YI
    Gene; 2013 Apr; 518(2):287-91. PubMed ID: 23414971
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Activity of 9-acridanone-hydrazone drugs detected at the pre-postural phase, in the experimental schistosomiasis mansoni.
    Pereira LH; Coelho PM; Costa JO; de Mello RT
    Mem Inst Oswaldo Cruz; 1995; 90(3):425-8. PubMed ID: 8544746
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Altered response of strain of Schistosoma mansoni to oxamniquine and praziquantel.
    Bonesso-Sabadini PI; de Souza Dias LC
    Mem Inst Oswaldo Cruz; 2002 Apr; 97(3):381-5. PubMed ID: 12048569
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effects of PEG-interferon-alpha-2A on Schistosoma mansoni infection in mice.
    Draz HM; Mahmoud SS; Ashour E; Shaker YM; Wu CH; Wu GY
    J Parasitol; 2010 Aug; 96(4):703-8. PubMed ID: 20486736
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Discovery and Characterization of Novel Anti-schistosomal Properties of the Anti-anginal Drug, Perhexiline and Its Impact on Schistosoma mansoni Male and Female Reproductive Systems.
    Guidi A; Lalli C; Perlas E; Bolasco G; Nibbio M; Monteagudo E; Bresciani A; Ruberti G
    PLoS Negl Trop Dis; 2016 Aug; 10(8):e0004928. PubMed ID: 27518281
    [TBL] [Abstract][Full Text] [Related]  

  • 13. In vivo effect of single oral dose of artemether against early juvenile stages of Schistosoma mansoni Egyptian strain.
    El-Beshbishi SN; Taman A; El-Malky M; Azab MS; El-Hawary AK; El-Tantawy DA
    Exp Parasitol; 2013 Oct; 135(2):240-5. PubMed ID: 23876575
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Anti-schistosomal drugs: observations on the mechanism of drug resistance to hycanthone, and on the involvement of host antibodies in the mode of action of praziquantel.
    Brindley PJ; Sher A
    Mem Inst Oswaldo Cruz; 1987; 82 Suppl 4():157-61. PubMed ID: 3151089
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Schistosoma mansoni: maturation rate and drug susceptibility of different geographic isolates.
    Fallon PG; Mubarak JS; Fookes RE; Niang M; Butterworth AE; Sturrock RF; Doenhoff MJ
    Exp Parasitol; 1997 May; 86(1):29-36. PubMed ID: 9149238
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Tegumental changes in adult Schistosoma mansoni harbored in mice treated with artemether.
    Xiao S; Shen B; Chollet J; Utzinger J; Tanner M
    J Parasitol; 2000 Oct; 86(5):1125-32. PubMed ID: 11128492
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Schistosoma mansoni: chemotherapy of infections of different ages.
    Sabah AA; Fletcher C; Webbe G; Doenhoff MJ
    Exp Parasitol; 1986 Jun; 61(3):294-303. PubMed ID: 3086114
    [TBL] [Abstract][Full Text] [Related]  

  • 18. In vitro and in vivo studies of the effect of artemether on Schistosoma mansoni.
    Xiao SH; Catto BA
    Antimicrob Agents Chemother; 1989 Sep; 33(9):1557-62. PubMed ID: 2510595
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Imatinib activity on Schistosoma mansoni.
    Katz N; Couto FF; Araújo N
    Mem Inst Oswaldo Cruz; 2013 Nov; 108(7):850-3. PubMed ID: 24037106
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Elucidation of the in vitro and in vivo activities of bridged 1,2,4-trioxolanes, bridged 1,2,4,5-tetraoxanes, tricyclic monoperoxides, silyl peroxides, and hydroxylamine derivatives against Schistosoma mansoni.
    Cowan N; Yaremenko IA; Krylov IB; Terent'ev AO; Keiser J
    Bioorg Med Chem; 2015 Aug; 23(16):5175-81. PubMed ID: 25744189
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.